BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8644803)

  • 1. Increased intraocular pressure after macular hole surgery.
    Thompson JT; Sjaarda RN; Glaser BM; Murphy RP
    Am J Ophthalmol; 1996 Jun; 121(6):615-22. PubMed ID: 8644803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of recombinant transforming growth factor-beta-2 and placebo as an adjunctive agent for macular hole surgery.
    Thompson JT; Smiddy WE; Williams GA; Sjaarda RN; Flynn HW; Margherio RR; Abrams GW
    Ophthalmology; 1998 Apr; 105(4):700-6. PubMed ID: 9544645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of intraocular bubble duration in the treatment of macular holes by vitrectomy and transforming growth factor-beta 2.
    Thompson JT; Glaser BM; Sjaarda RN; Murphy RP; Hanham A
    Ophthalmology; 1994 Jul; 101(7):1195-200. PubMed ID: 8035983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SULFURHEXAFLUORIDE (SF6) VERSUS PERFLUOROPROPANE (C3F8) GAS AS TAMPONADE IN MACULAR HOLE SURGERY.
    Modi A; Giridhar A; Gopalakrishnan M
    Retina; 2017 Feb; 37(2):283-290. PubMed ID: 28118283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The results of vitreous surgery for chronic macular holes.
    Thompson JT; Sjaarda RN; Lansing MB
    Retina; 1997; 17(6):493-501. PubMed ID: 9428011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of apraclonidine 1% in preventing intraocular pressure rise following macular hole surgery.
    Sciscio A; Casswell AG
    Br J Ophthalmol; 2001 Feb; 85(2):164-8. PubMed ID: 11159479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraocular tamponade duration and success of macular hole surgery.
    Thompson JT; Smiddy WE; Glaser BM; Sjaarda RN; Flynn HW
    Retina; 1996; 16(5):373-82. PubMed ID: 8912962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glaucoma after macular hole surgery.
    Chen CJ
    Ophthalmology; 1998 Jan; 105(1):94-9; discussion 99-100. PubMed ID: 9442784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progression of nuclear sclerosis and long-term visual results of vitrectomy with transforming growth factor beta-2 for macular holes.
    Thompson JT; Glaser BM; Sjaarda RN; Murphy RP
    Am J Ophthalmol; 1995 Jan; 119(1):48-54. PubMed ID: 7825689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. To posture or not to posture after macular hole surgery.
    Dhawahir-Scala FE; Maino A; Saha K; Mokashi AA; McLauchlan R; Charles S
    Retina; 2008 Jan; 28(1):60-5. PubMed ID: 18185139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gas injection versus vitrectomy with gas for treating retinal detachment owing to macular hole in high myopes.
    Li X; Wang W; Tang S; Zhao J
    Ophthalmology; 2009 Jun; 116(6):1182-87.e1. PubMed ID: 19375168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of sulfur hexafluoride (SF6) versus perfluoropropane (C3F8) gas tamponade for macular hole surgery.
    Kim SS; Smiddy WE; Feuer WJ; Shi W
    Retina; 2008; 28(10):1408-15. PubMed ID: 18827734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of reopened macular hole after vitrectomy by laser and outpatient fluid-gas exchange.
    Ohana E; Blumenkranz MS
    Ophthalmology; 1998 Aug; 105(8):1398-403. PubMed ID: 9709749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective randomized trial of vitrectomy or observation for stage 2 macular holes. Vitrectomy for Macular Hole Study Group.
    Kim JW; Freeman WR; Azen SP; el-Haig W; Klein DJ; Bailey IL
    Am J Ophthalmol; 1996 Jun; 121(6):605-14. PubMed ID: 8644802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of different techniques of intraocular gas tamponade in the treatment of retinal detachment due to macular hole.
    Garcia-Arumi J; Correa CA; Corcostegui B
    Ophthalmologica; 1990; 201(2):83-91. PubMed ID: 2234820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postoperative intraocular pressure abnormalities in the Silicone Study. Silicone Study Report 4.
    Barr CC; Lai MY; Lean JS; Linton KL; Trese M; Abrams G; Ryan SJ; Azen SP
    Ophthalmology; 1993 Nov; 100(11):1629-35. PubMed ID: 8233387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant methods in macular hole surgery: intraoperative plasma-thrombin mixture and postoperative fluid-gas exchange.
    Blumenkranz MS; Ohana E; Shaikh S; Chang S; Coll G; Morse LS; De Bustros S
    Ophthalmic Surg Lasers; 2001; 32(3):198-207. PubMed ID: 11371086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pars plana vitrectomy and perfluoropropane (C3F8) tamponade for retinal detachment due to myopic macular hole: a prognostic factor analysis.
    Lam RF; Lai WW; Cheung BT; Yuen CY; Wong TH; Shanmugam MP; Lam DS
    Am J Ophthalmol; 2006 Dec; 142(6):938-44. PubMed ID: 17157579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical management of macular holes: results using gas tamponade alone, or in combination with autologous platelet concentrate, or transforming growth factor beta 2.
    Minihan M; Goggin M; Cleary PE
    Br J Ophthalmol; 1997 Dec; 81(12):1073-9. PubMed ID: 9497468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitrectomy, fluid-gas exchange and transforming growth factor--beta-2 for the treatment of traumatic macular holes.
    Rubin JS; Glaser BM; Thompson JT; Sjaarda RN; Pappas SS; Murphy RP
    Ophthalmology; 1995 Dec; 102(12):1840-5. PubMed ID: 9098285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.